Prot #KD025-215: A Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  • Correia, Chase Stephen (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date1/21/211/21/24

Funding

  • Kadmon Corporation, LLC (Prot #KD025-215)